Tobradex is a brand-name ophthalmic solution that contains the antibiotics tobramycin (0.3 %) and the corticosteroid dexamethasone (0.1 %). It is supplied in a sterile bottle for topical eye use. In Hong Kong, Tobradex is classified as a prescription-only ophthalmic product and is regulated by the Pharmacy and Poisons Board under the Department of Health.
Tobradex is approved in Hong Kong for the treatment of bacterial conjunctivitis, keratitis, and other superficial eye infections where inflammation is present. It is also indicated for postoperative ocular inflammation when a bacterial infection risk exists. The product is intended for adult patients and for children when specifically prescribed by an ophthalmologist.
No robust peer-reviewed evidence currently supports off-label uses of Tobradex. Healthcare providers may consider individual circumstances, but any non-approved application should be undertaken only under specialist supervision and with appropriate risk assessment.
Absolute Contraindications
Relative Contraindications
Special Populations
Patients should disclose all current medications, including over-the-counter eye products, to their ophthalmologist before starting Tobradex.
This article provides educational information about Tobradex and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Tobradex contains an antibiotic and a steroid; while the steroid component can reduce allergic inflammation, the antibiotic is unnecessary for non-infectious allergies. Using it for purely allergic conjunctivitis is generally not recommended without a clinician’s assessment.
After opening, the bottle should be used within 30 days, even if the printed expiration date is later, to ensure sterility and prevent contamination.
Spit the liquid out and rinse the mouth with water. Contact a healthcare professional or poison control centre if a large amount was swallowed.
Patients should remove contact lenses before instilling Tobradex and wait at least 15 minutes before reinserting them to avoid trapping the medication and reducing efficacy.
Yes, but keep the bottle in its original packaging, include a copy of the prescription, and declare it at customs if required by the destination country’s regulations.
Swimming can introduce contaminants to the eye and diminish the medication’s effect. It is advisable to avoid swimming until the treatment course is completed.
Combining the two agents in one bottle simplifies dosing and may improve adherence, but the fixed ratio is not adjustable. Separate drops allow clinicians to tailor the dosage of each component individually.
Typical ophthalmic solutions contain buffers (e.g., sodium phosphate), tonicity agents (e.g., sodium chloride), and preservatives such as benzalkonium chloride. Exact inactive ingredients should be confirmed from the product label.
Artificial tears can be used a few minutes apart from Tobradex to alleviate dryness. Administer Tobradex first, wait several minutes, then apply the lubricating drops.
Long-term use of corticosteroid eye drops may increase the risk of posterior subcapsular cataract formation. Short courses for infection-related inflammation have a much lower risk, but monitoring is advised for prolonged therapy.